Rho kinase pathway is likely responsible for the profibrotic actions of aldosterone in renal epithelial cells via inducing epithelial-mesenchymal transition and extracellular matrix excretion

Cell Biology International

Volumn 37, Issue 7, 2013, Pages 725-730

  Wei, Jiali ^a   Li, Zhuori ^a   Ma, Chunyang ^b   Zhan, Feng ^a   Wu, Wei ^a   Han, Hui ^a   Huang, Yun ^a   Li, Wenning ^a   Chen, Daojun ^a   Peng, Youming ^c  

^a HAINAN GENERAL HOSPITAL   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Aldosterone; Epithelial mesenchymal transition; Extracellular matrix; Kidney; Renal epithelial cell; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALDOSTERONE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; EPLERENONE; MESSENGER RNA; RHO KINASE; UVOMORULIN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HORMONE ACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CELL; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84880687429     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1002/cbin.10082     Document Type: Article

References (34)

1. Chen L, Necela BM, Su W, Yanagisawa M, Anastasiadis PZ, Fields AP, Thompson EA (2006) Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by Rho GTPase-dependent activation of ERK1/2. J Biol Chem 281: 24575-87.
2. Colvin RB (2003) Chronic allograft nephropathy. N Engl J Med 349: 2288-90
3. Das S, Becker BN, Hoffmann FM, Mertz JE (2009) Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway. BMC Cell Biol 10: 94.
4. Eddy AA (1996) Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol. 7: 2495-508.
5. Essawy M, Soylemezoglu O, Muchaneta-Kubara EC, Shortland J, Brown CB, el Nahas AM (1997) Myofibroblasts and the progression of diabetic nephropathy Nephrol Dial Transplant 12: 43-50.
6. Fan YY, Baba R, Nagai Y, Miyatake A, Hosomi N, Kimura S, Sun GP, Kohno M, Fujita M, Abe Y, Nishiyama A (2006) Augmentation of intrarenal angiotensin II levels inuninephrectomized aldosterone/salt-treated hypertensive rats;renoprotective effects of an ultrahigh dose of olmesartan.Hypertens Res 29: 169-78.
7. Greene EL, Kren S, Hostetter TH (1996) Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98: 1063-8.
8. Halloran PF, Melk A, Barth C (1999) Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 10: 167-81.
9. Horiuchi M,Nishiyama H,Hama J, Takenaka T, Kondo H, KinoH, Nagata S, Sugimura K, Katori R (1993) Characterization of renal aldosterone receptors in genetically hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 264: F286-91.
10. Ishizaki T, Maekawa M, Fujisawa K, Okawa K, Iwamatsu A, Fujita A, Watanabe N, Saito Y, Kakizuka A, Morii N, Narumiya S (1996) The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase EMBO J 15: 1885-93.
11. Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T (2003) Effect of fasudil on Rho kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats, Kidney Int 64: 2009-19.
12. Kiyomoto H, Rafiq K, Mostofa M, Nishiyama A (2008) Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury. J Pharmacol Sci 108: 399-405.
13. Leung T, Chen XQ, Manser E, Lim L (1996) The p160 RhoAbinding kinase ROK a is a member of a kinase family and is involved in the reorganization of the cytoskeleton.Mol Cell Biol 16: 5313-27.
14. Liu Y (2004) Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12.
15. Macconi D (2010) Targeting the renin angiotensin system for remission/regression of chronic kidney disease. Histol Histopathol. 25: 655-68.
16. Manotham K, Tanaka T, Matsumoto M, Ohse T, Inagi R, Miyata T, Kurokawa K, Fujita T, Ingelfinger JR, Nangaku M (2004) Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 65: 871-80.
17. Masszi A, Di Ciano C, Sirokmány G, Arthur WT, Rotstein OD, Wang J, McCulloch CA, Rosivall L, Mucsi I, Kapus A (2003) Central role for Rho in TGF-beta1-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am J Physiol Renal Physiol 284: F911-24.
18. Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K (1996) Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 15: 2208-16.
19. Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M, Nishiyama A (2005) Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 46: 1039-45.
20. Nagatoya K,Moriyama T, Kawada N, Takeji M, Oseto S,Murozono T, Ando A, Imai E, Hori M (2002) Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 61: 1684-95.
21. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S (1996) ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 392: 189-93.
22. Nangaku M (2004) Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 43: 9-17.
23. Nishiyama A, Abe Y (2006) Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade. J Pharmacol Sci 100: 9-16.
24. Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y (2004) Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/ salt-induced hypertensive rats. Hypertension 43: 841-8.
25. Patel S, Takagi KI, Suzuki J, Imaizumi A, Kimura T, Mason RM, Kamimura T, Zhang Z (2005) RhoGTPase activation is a key step in renal epithelial mesenchymal transdifferentiation. J Am Soc Nephrol 16: 1977-84.
26. Patni H, Mathew JT, Luan L, Franki N, Chander PN, Singhal PC (2007) Aldosterone promotes proximal tubular cell apoptosis: role of oxidative stress. Am J Physiol Renal Physiol 293: F1065- 71.
27. Port FK, Fenton SSA, Mazzuchi N (2000) ESRD throughout the world: morbidity, mortality and quality of life. Kidney Int 57: S1-S2.
28. Remuzzi G, Bertani T (1998) Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-56.
29. Roberts IS, Burrows C, Shanks JH, Venning M, McWilliam LJ (1997) Interstitial myofibroblasts: predictors of progression in membranous nephropathy. J Clin Pathol 50: 123-7.
30. Rupérez M, Sánchez-López E, Blanco-Colio LM, Esteban V, Rodríguez-Vita J, Plaza JJ, Egido J, Ruiz-Ortega M (2005) The Rho-kinase pathway regulates angiotensin II-induced renal damage. Kidney Int Suppl 99: S39-45.
31. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A (2003) Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112: 1486-94.
32. Sun GP, Kohno M, Guo P, Nagai Y, Miyata K, Fan YY, Kimura S, Kiyomoto H, Ohmori K, Li DT, Abe Y, Nishiyama A (2006) Involvements of Rho-kinase and TGF-beta pathways inaldosterone- induced renal injury. J Am Soc Nephrol 17: 2193-201
33. Tang WW, Ulich TR, Lacey DL, Hill DC, Qi M, Kaufman SA, Van GY, Tarpley JE, Yee JS (1996) Platelet-derived growth factor-BB induces renal interstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 148: 1169-80.
34. Zhang A, Jia Z, Guo X, Yang T (2007) Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol 293: F723-31.